LAQUEL PRESSLEY: Open Payments
NPI 1306585831 · APPLE VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,041 in 68 payments from 11 companies in 2025. Trend: 2023 $598 · 2024 $838 · 2025 $2,041
Food & beverage: $2,041
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $439 |
| ABBVIE INC. | 15 | $317 |
| Alkermes, Inc. | 14 | $313 |
| Otsuka America Pharmaceutical, Inc. | 9 | $244 |
| Vanda Pharmaceuticals Inc. | 5 | $228 |
| E.R. Squibb & Sons, L.L.C. | 11 | $173 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Lundbeck LLC | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, FANAPT, COBENFY, ABILIFY MAINTENA, Auvelity, REXULTI.
Industry payments across CA — which companies pay providers there.
